NO985720L - Aerosol legemiddelformuleringer av formoterol - Google Patents

Aerosol legemiddelformuleringer av formoterol

Info

Publication number
NO985720L
NO985720L NO985720A NO985720A NO985720L NO 985720 L NO985720 L NO 985720L NO 985720 A NO985720 A NO 985720A NO 985720 A NO985720 A NO 985720A NO 985720 L NO985720 L NO 985720L
Authority
NO
Norway
Prior art keywords
formoterol
drug formulations
aerosol drug
aerosol
formulations
Prior art date
Application number
NO985720A
Other languages
English (en)
Other versions
NO320403B1 (no
NO985720D0 (no
Inventor
Martin J Oliver
Simon G Paling
Philip A Jinks
Sukhbinder K Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO985720(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of NO985720D0 publication Critical patent/NO985720D0/no
Publication of NO985720L publication Critical patent/NO985720L/no
Publication of NO320403B1 publication Critical patent/NO320403B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19985720A 1996-06-11 1998-12-07 Farmasoytisksuspensjonsformulering av formoterol egnet for aerosoladministrering, aerosolleverende anordning og fremgangsmate til fremstilling av aerosolformulering NO320403B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations
PCT/US1997/009471 WO1997047286A1 (en) 1996-06-11 1997-06-02 Medicinal aerosol formulations of formoterol

Publications (3)

Publication Number Publication Date
NO985720D0 NO985720D0 (no) 1998-12-07
NO985720L true NO985720L (no) 1999-02-11
NO320403B1 NO320403B1 (no) 2005-11-28

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985720A NO320403B1 (no) 1996-06-11 1998-12-07 Farmasoytisksuspensjonsformulering av formoterol egnet for aerosoladministrering, aerosolleverende anordning og fremgangsmate til fremstilling av aerosolformulering

Country Status (16)

Country Link
EP (2) EP0934057B1 (no)
JP (1) JP5000793B2 (no)
AR (1) AR009231A1 (no)
AT (1) ATE275940T1 (no)
AU (1) AU726382B2 (no)
CA (1) CA2257841C (no)
DE (1) DE69730723T2 (no)
DK (1) DK0934057T3 (no)
ES (1) ES2229366T3 (no)
GB (1) GB9612297D0 (no)
ID (1) ID19520A (no)
NO (1) NO320403B1 (no)
NZ (1) NZ333202A (no)
PT (1) PT934057E (no)
WO (1) WO1997047286A1 (no)
ZA (1) ZA974546B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DK1121112T3 (da) * 1998-10-17 2002-09-16 Boehringer Ingelheim Pharma Lagringsdygtigt koncentrat af aktivt stof med formoterol
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
EE05167B1 (et) 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
SI1542904T1 (sl) * 2002-08-27 2008-06-30 Schering Corp Postopek za izdelavo inhalacijskih formulacij z merjenim odmerkom
AU2004246819A1 (en) 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT2435025T (pt) * 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
WO2011038872A1 (en) 2009-10-02 2011-04-07 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460064A4 (en) * 1989-02-23 1992-04-01 Rorer International (Holdings) Inc. Therapeutic aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
PT656206E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
US6503482B1 (en) * 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
DK0717987T3 (da) * 1991-12-18 2001-11-12 Minnesota Mining & Mfg Suspension-aerosol-formuleringer
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
EP0934057B1 (en) 2004-09-15
AR009231A1 (es) 2000-04-12
NZ333202A (en) 2000-06-23
ATE275940T1 (de) 2004-10-15
AU3373997A (en) 1998-01-07
DE69730723D1 (de) 2004-10-21
EP1400239A1 (en) 2004-03-24
GB9612297D0 (en) 1996-08-14
JP5000793B2 (ja) 2012-08-15
EP0934057A1 (en) 1999-08-11
ES2229366T3 (es) 2005-04-16
AU726382B2 (en) 2000-11-02
NO320403B1 (no) 2005-11-28
NO985720D0 (no) 1998-12-07
DK0934057T3 (da) 2005-01-24
WO1997047286A1 (en) 1997-12-18
PT934057E (pt) 2004-12-31
CA2257841A1 (en) 1997-12-18
CA2257841C (en) 2008-05-20
ZA974546B (en) 1998-11-23
DE69730723T2 (de) 2005-10-06
JP2000513340A (ja) 2000-10-10
ID19520A (id) 1998-07-16

Similar Documents

Publication Publication Date Title
NO985720D0 (no) Aerosol legemiddelformuleringer av formoterol
DE69530325D1 (de) Aerosol-arzneiformulierungen
FI953515L (fi) Fluoksetiinin farmaseuttiset formulaatiot
IT1293803B1 (it) Formulazioni di aerosol medicinali
ATE320246T1 (de) Medizinische aerosolformulierungen enthaltend budesonide
NO981967L (no) Stabile fryset°rkede farmas°ytiske formuleringer
DK1073417T3 (da) Farmaceutisk aerosolformulering
DK0927037T3 (da) Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider
FI953887A7 (fi) Kefaklorin farmaseuttisia formulaatioita
ID18832A (id) Komposisi insektisida
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
ID16781A (id) Formulasi-formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
ID23774A (id) Komposisi insektisida
SE9404467D0 (sv) Drug formulations
SE9404469D0 (sv) Aerosol formulations
SE9502453D0 (sv) Drug formulations
SE9502452D0 (sv) Aerosol formulations
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
SE9600141D0 (sv) Pharmaceutical formulation